stroke-related insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years; 2. Patients with acute ischemic stroke within 72 hours of first onset (with symptoms associated with sudden neurological impairment); 3. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Brain CT or MR diagnosis of cerebral hemorrhage or other brain diseases, such as intracranial tumor, abscess, metabolic encephalopathy; 2. There were only isolated visual changes, isolated sensory symptoms (such as numbness), isolated dizziness or vertigo, and no evidence of acute ischemic stroke on craniocerebral imaging (CT or MRI); 3. MRS score > 2; 4. The severity of this acute ischemic stroke resulted in long-term bedridden patients or MRS score > 3; 5. Patients who plan or may have any form of surgery within the next 3 months; 6. Patients who have previously been diagnosed with anxiety or depression disorder and are taking or require long-term use of anti-anxiety/depression medications; 7. Patients with refractory insomnia in the past and need to take drugs to assist sleep for a long time; 8. Women of reproductive age who are pregnant or planning to become pregnant, and women who are breastfeeding; 9. Patients with malignant tumor or other serious non-cardiovascular and cerebrovascular diseases, the expected survival time is less than 3 months; 10. Participated in other clinical drug or device studies within 30 days; 11. Inability to understand and/or comply with study follow-up due to severe cognitive impairment or mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum hypocretin; | — |
Countries
China
Contacts
Shenzhen Second People's Hospital